13F Holdings
中文EN

USPH U S PHYSICAL THERAPY INC /NV

Services-Health Services · NYSE · SEC CIK 885978 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY10.4%
TTM net income YoY-32.5%
TTM EPS YoY-156.1%
Revenue 3-yr CAGR12.3%
Net income 3-yr CAGR-0.1%

Margins

Gross margin18.8%
Operating margin9.1%
Net margin3.6%
FCF margin8.2%
EBITDA margin11.7%

Returns

ROE6.5%
ROA2.4%
ROIC (approx.)9.1%
Asset turnover0.67x

Leverage & solvency

Liabilities / assets39.2%
Debt / equity0.57x
Current ratio1.42x
Interest coverage—

Cash quality & payout

Operating cash flow / net income2.95x
Accruals ratio-4.7%
Payout ratio—
Capex / revenue2.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$780.99M$671.35M$604.80M$553.14M$495.02M
Gross profit$149.69M$123.92M$121.51M$112.02M$117.18M
SG&A expense$69.26M$58.29M$51.95M$46.11M$46.53M
Operating income$86.68M$62.99M$50.51M$56.80M$70.65M
Pretax income$77.81M$60.21M$49.38M$55.57M$73.20M
Income tax$19.81M$14.61M$12.16M$12.16M$15.27M
Net income$39.58M$31.42M$28.24M$32.16M$40.83M
EBITDA$109.07M$81.67M$66.21M$71.54M$82.24M
EPS (basic)1.421.841.282.252.41
EPS (diluted)1.421.841.282.252.41
Dividends declared per share1.801.761.721.641.46
Weighted avg. shares (diluted)15.18M15.06M14.19M12.98M12.90M
Balance sheet
Cash & equivalents$35.57M$41.36M$152.82M$31.59M$28.57M
Receivables$64.25M$59.04M$51.80M$51.90M$46.27M
Current assets$139.99M$137.58M$233.38M$111.27M$95.17M
PP&E, net$35.65M$32.14M$26.10M$24.75M$22.98M
Goodwill$692.39M$667.15M$509.57M$494.10M$434.68M
Intangibles$172.86M$179.31M$109.68M$108.75M$86.38M
Total assets$1.20B$1.17B$997.24M$858.15M$749.43M
Current liabilities$139.04M$116.28M$102.19M$85.49M$83.48M
Short-term debt$9.87M$11.00M$7.69M$7.86M$830,000
Long-term debt$152.59M$142.53M$138.99M$175.83M$117.59M
Total debt$162.46M$153.53M$146.68M$183.69M$118.42M
Total liabilities$433.81M$408.42M$345.00M$373.59M$296.98M
Shareholders' equity$476.43M$488.93M$476.19M$315.79M$295.61M
Net debt$126.89M$112.17M-$6.14M$152.10M$89.85M
Cash flow statement
Operating cash flow$75.06M$74.94M$81.98M$58.54M$76.41M
Capital expenditure$14.07M$9.19M$9.29M$8.25M$8.20M
Free cash flow$60.99M$65.75M$72.68M$50.29M$68.20M
Investing cash flow-$36.71M-$149.45M-$45.02M-$81.27M-$124.14M
Financing cash flow-$44.14M-$36.95M$84.27M$25.76M$43.38M
Depreciation & amortization$22.39M$18.68M$15.70M$14.74M$11.59M
Stock-based compensation$8.27M$7.82M$7.24M$7.26M$7.87M
Dividends paid$27.36M$26.54M$24.13M$21.32M$18.77M
Share buybacks$5.57M$0$0——

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.